Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$ALMR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.22 up 64.52% YoY • Reported revenue of $29.43M up 82.08% YoY • Alamar Biosciences expects full year 2026 revenue to be in the range of $116 million to $120 million, representing growth of 59% at the midpoint of the range compared to 2025.

Price since post

Full Details

Advertisement|Remove ads.